Specialty
Certifications
Nephrology
Education
MD, Yale University School of Medicine
Residency, Internal Medicine
Columbia-Presbyterian Medical Ctr.Fellowship, Nephrology
Columbia-Presbyterian Medical Ctr.Fellowship, Nephrology Transplant
Columbia-Presbyterian Medical Ctr.
Biography
Dr. Sehgal earned her M.D. at Yale University School of Medicine and went on to do her residency in Internal Medicine at Columbia-Presbyterian Medical Center here in New York City. She completed a fellowship in Nephrology and a fellowship in Transplant Nephrology also at Columbia-Presbyterian. Among her many honors, Dr. Sehgal was recognized as a John Harvard Scholar at Harvard University in 1986 where she graduated Cum Laude. Dr. Sehgal is board certified in Internal Medicine and Nephrology.
Dr. Sehgal's society memberships include the American Society of Nephrology, American College of Physicians and the New York State Society of Nephrology.
Research
Transplant nephrology
Clinical research interest in the medical complications of transplantation, including hepatitis C, post-transplant diabetes, bone disease, and hypercoagulable states.
Publications
Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation:cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995; 26(1): 193-201.
Goldstein DI, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen DJ. Cyclosporine-associated end-stage nephropathy after cardiac transplantation:incidence and progression. Transplantation 1997; 63(5): 664-668.
Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Intravenous Immunoglobulin and thymoglobulin facilitate kidney transplantation in complement dependent cytotoxicity B cell and flow cytometry (T and/or B cell) cross-match positive patients. Transplantation 2003; 76(10): 1444-1447.
Akalin E, Sehgal V, Ames S, Hossain S, Daly L, Murphy B, Bromberg JS. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. American Journal of Transplantation 2003; 3(6): 731-735.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sehgal during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Wyeth (Pfizer, Inc.)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
5 East 98th Street
12th Floor
New York, NY 10029
Fax: 212-348-2474
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- Aetna
- Anthem Health
- Blue Choice
- Devon Health Services
- Empire Blue Cross/Blue Shield
- Fidelis Care NY - HMO
- GHI HMO Select, Inc.
- Health Insurance Plan (HIP)
- Island Group
- Medicaid
- Medicare
- PHS/Healthnet/Guardian
- Prem Preferred Care/Beechstreet
- Private Healthcare Systems (PHCS)
- Railroad Medicare
- SelectPRO
- United Health Care Empire Plan
- United Healthcare
- Worker's Compensation